Michelle L DeSilvio

Author PubWeight™ 14.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.	JAMA	2005	7.59
2	Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.	J Clin Oncol	2013	2.44
3	Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.	J Clin Oncol	2008	1.78
4	Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups.	Int J Radiat Oncol Biol Phys	2006	1.62
5	Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen.	Breast Cancer Res Treat	2012	0.89
6	Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?	J Natl Cancer Inst	2003	0.78